HER2 Low Advanced or Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HER2 Low Advanced or Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer. (NCT05792410) | Jiangsu HengRui Medicine Co., Ltd. | 2023-04-01 |
Track HER2 Low Advanced or Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.